Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Agarwal, Anup; Mukherjee, Aparna; Kumar, Gunjan; Chatterjee, Pranab; Bhatnagar, Tarun; Malhotra, Pankaj

doi:10.1136/bmj.m3939

Public

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

Published in BMJ • Oct 22, 2020

Authors:

Anup Agarwal

Aparna Mukherjee

Gunjan Kumar

Abstract

OBJECTIVE: To investigate the effectiveness of using convalescent plasma to treat moderate coronavirus disease 2019 (covid-19) in adults in India. DESIGN: Open label, parallel arm, phase II, multicentre, randomised controlled trial. SETTING: 39 public and private hospitals across India. PARTICIPANTS...

Subject

Medicine

Confidence interval

Fraction of inspired oxygen

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!